{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:22:07Z","timestamp":1794270127219,"version":"4.9.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ijantimicag.2026.107900","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:50:52Z","timestamp":1783353052000},"page":"107900","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mechanisms underlying altered ceftazidime-avibactam resistance in Klebsiella pneumoniae driven by KPC-234 mutation and IncX3-NDM-1 plasmid transfer"],"prefix":"10.1016","volume":"67","author":[{"given":"Yunqi","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengkang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renru","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0417-158X","authenticated-orcid":false,"given":"Dandan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4493-0619","authenticated-orcid":false,"given":"Fupin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2026.107900_bib0001","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1093\/infdis\/jiw282","article-title":"The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace","volume":"215","author":"Logan","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107900_bib0002","unstructured":"China Antimicrobial Surveillance Network (CHINET). Surveillance of bacterial resistance in China, 2024. http:\/\/www.chinets.com."},{"key":"10.1016\/j.ijantimicag.2026.107900_bib0003","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3389\/fcimb.2020.00314","article-title":"Dissemination of carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) among carbapenem-resistant Enterobacteriaceae isolated from adult and children patients in China","volume":"10","author":"Han","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ijantimicag.2026.107900_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.956044","article-title":"A selective medium for screening ceftazidime\/avibactam resistance in carbapenem-resistant Enterobacterales","volume":"13","author":"Zeng","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2026.107900_bib0005","series-title":"Performance standards for antimicrobial susceptibility testing","year":"2025"},{"key":"10.1016\/j.ijantimicag.2026.107900_bib0006","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 14.0, 2024. https:\/\/www.eucast.org\/clinical_breakpoints."},{"key":"10.1016\/j.ijantimicag.2026.107900_bib0007","unstructured":"U.S. Food and Drug Administration. Tigecycline for injection: highlights of prescribing information. 2023. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/021821s059lbl.pdf."},{"key":"10.1016\/j.ijantimicag.2026.107900_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107265","article-title":"Complex evolutionary trajectories in vivo of two novel KPC variants conferring ceftazidime-avibactam resistance","volume":"64","author":"Tang","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2026.107900_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005595","article-title":"Unicycler: resolving bacterial genome assemblies from short and long sequencing reads","volume":"13","author":"Wick","year":"2017","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.ijantimicag.2026.107900_bib0010","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1038\/s41467-021-24448-3","article-title":"A genomic surveillance framework and genotyping tool for Klebsiella pneumoniae and its related species complex","volume":"12","author":"Lam","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijantimicag.2026.107900_bib0011","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1128\/AAC.02412-14","article-title":"In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing","volume":"58","author":"Carattoli","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107900_bib0012","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1093\/jac\/dks261","article-title":"Identification of acquired antimicrobial resistance genes","volume":"67","author":"Zankari","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107900_bib0013","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4103\/0366-6999.221267","article-title":"Risk factors for carbapenem-resistant Klebsiella pneumoniae infection and mortality of Klebsiella pneumoniae infection","volume":"131","author":"Wang","year":"2018","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.ijantimicag.2026.107900_bib0014","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jceh.2022.04.016","article-title":"Ceftazidime-avibactam for the treatment of carbapenem-resistant Klebsiella pneumoniae infections in patients with liver cirrhosis","volume":"12","author":"Feldman","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.ijantimicag.2026.107900_bib0015","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00883-17","article-title":"Ceftazidime-avibactam is superior to other treatment regimens against carbapenem-resistant Klebsiella pneumoniae bacteremia","volume":"61","author":"Shields","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107900_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106111","article-title":"Assessment of the in vitro activity of ceftazidime\/avibactam against a global collection of multidrug-resistant Klebsiella spp. From the INFORM surveillance programme (2015-2017)","volume":"56","author":"Rossolini","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2026.107900_bib0017","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00008-23","article-title":"Klebsiella pneumoniae carbapenemase variants: the new threat to global public health","volume":"36","author":"Ding","year":"2023","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2026.107900_bib0018","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1093\/jac\/dkaa283","article-title":"Bloodstream infection by two subpopulations of Klebsiella pneumoniae ST1685 carrying KPC-33 or KPC-14 following ceftazidime\/avibactam treatment: considerations regarding acquired heteroresistance and choice of carbapenemase detection assay","volume":"75","author":"Bianco","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107900_bib0019","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jgar.2021.02.008","article-title":"Carbapenemase detection testing in the era of ceftazidime\/avibactam-resistant KPC-producing Enterobacterales: a 2-year experience","volume":"24","author":"Bianco","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ijantimicag.2026.107900_bib0020","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/s41467-022-28819-2","article-title":"Role of mobile genetic elements in the global dissemination of the carbapenem resistance gene bla(NDM)","volume":"13","author":"Acman","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijantimicag.2026.107900_bib0021","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00447-22","article-title":"Klebsiella pneumoniae carbapenemase variants resistant to ceftazidime-avibactam: an evolutionary overview","volume":"66","author":"Hobson","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107900_bib0022","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1093\/jac\/dkz330","article-title":"Emergence of ceftazidime\/avibactam resistance in KPC-3-producing Klebsiella pneumoniae in vivo","volume":"74","author":"Gottig","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107900_bib0023","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1093\/jac\/dkaa241","article-title":"Phenotypic and genotypic analysis of KPC-51 and KPC-52, two novel KPC-2 variants conferring resistance to ceftazidime\/avibactam in the KPC-producing Klebsiella pneumoniae ST11 clone background","volume":"75","author":"Sun","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107900_bib0024","doi-asserted-by":"crossref","first-page":"S436","DOI":"10.1093\/cid\/ciaa1521","article-title":"Emergence and recovery of ceftazidime-avibactam resistance in blaKPC-33-harboring Klebsiella pneumoniae sequence type 11 isolates in China","volume":"71","author":"Shi","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107900_bib0025","first-page":"1631","article-title":"Ceftazidime-avibactam in combination with Imipenem as salvage therapy for ST11 KPC-33-producing Klebsiella pneumoniae","volume":"11","author":"Ding","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijantimicag.2026.107900_bib0026","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jgar.2020.10.019","article-title":"Aztreonam plus ceftazidime-avibactam as treatment of NDM-1-producing Klebsiella pneumoniae bacteraemia in a neutropenic patient: last resort therapy?","volume":"23","author":"Bocanegra-Ibarias","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ijantimicag.2026.107900_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2019.102599","article-title":"The transferability and evolution of NDM-1 and KPC-2 co-producing Klebsiella pneumoniae from clinical settings","volume":"51","author":"Gao","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ijantimicag.2026.107900_bib0028","first-page":"1491","article-title":"Insight into the mechanisms of carbapenem resistance in Klebsiella pneumoniae: a study on IS26 integrons, beta-lactamases, porin modifications, and plasmidome analysis","volume":"12","author":"Tseng","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijantimicag.2026.107900_bib0029","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3390\/microorganisms8030377","article-title":"Fitness cost of bla(NDM-5)-carrying p3R-IncX3 plasmids in wild-type NDM-free Enterobacteriaceae","volume":"8","author":"Ma","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.ijantimicag.2026.107900_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107290","article-title":"Genomic characterisation of a multidrug-resistant Klebsiella pneumoniae co-harbouring bla(NDM-1), bla(KPC-2), and tet(A) isolated from the bloodstream infections of patients","volume":"64","author":"Zhang","year":"2024","journal-title":"Int J Antimicrob Agents"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926001871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926001871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:37:49Z","timestamp":1794267469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857926001871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0924857926001871"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107900","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms underlying altered ceftazidime-avibactam resistance in Klebsiella pneumoniae driven by KPC-234 mutation and IncX3-NDM-1 plasmid transfer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107900","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107900"}}